Brief: Molecure To Begin Phase II Clinical Trial Of OATD-01 In US

Molecure SA

24/07/2023 06:36

July 24 (Reuters) - Molecure SA  MOCP.WA :
    * SAID ON SATURDAY THAT US FOOD AND DRUG ADMINISTRATION
(FDA)
APPROVED ITS INVESTIGATIONAL NEW DRUG (IND) MOTION FOR OATD-01
MOLECULE
    * THIS APPROVAL ALLOWS FOR COMPANY TO BEGIN PHASE II
CLINICAL
TRIALS OF OATD-01 IN US
    * TESTS ARE EXPECTED TO DETERMINE OATD-01 EFFECTIVENESS IN
TREATING PATIENTS WITH ACTIVE PULMONARY SARCOIDOSIS
    * ESTIMATES THAT FIRST PATIENT WILL BE INCORPORATED IN Q4
    * AROUND 90 PEOPLE ARE EXPECTED TO TAKE PART IN TRIAL
 

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nEM46Rjy5a
 Further company coverage:  MOCP.WA  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))